CELL INTELLIGENCE · 肿瘤细胞治疗研究

iPSC 来源 CD19 CAR NK 细胞治疗复发/难治性淋巴瘤

iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma.

在多拷贝 rDNA 位点定点整合 CAR19 和 IL24 的 iPSC 来源 NK 细胞增强抗肿瘤活性和增殖

iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation.

MUC1 靶向 CAR-NK 细胞抗人舌鳞状细胞癌的疗效

Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma.

靶向 MUC1 的 CAR-NK 细胞对人 OTSCC 具有显著疗效，其令人期待的治疗反应值得进一步开展临床试验。

人诱导多能干细胞来源抗 CD19 嵌合抗原受体 NK 细胞的制备与功能表征

Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells.

CAR-T 细胞治疗血液系统恶性肿瘤的进展

Progress on CAR-T cell therapy for hematological malignancies.